文献

Background Information:

AZD0530 is an orally bioavailable inhibitor of protein tyrosine kinases, targeting Src and Abl.

Reference:

1. Chang, YM, et al., Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene 2008, 1–11.
2. Dulsat, C, et al., Saracatinib. Drugs Fut. 2009, 34(2), 106.

APIM050089: AZD0530

CAS No.: 379231-04-6.
Molecular Formula: C27H32ClN5O5.
Molecular Weight: 542.03.
Purity: > 99% (HPLC).
QC: 1HNMR, HPLC.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.